Osamu Ichiyanagi
Overview
Explore the profile of Osamu Ichiyanagi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
121
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurota Y, Takeda Y, Ichiyanagi O, Saitoh S, Ito H, Naito S, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37239002
Background: The regulation of the redox balance in the tumor microenvironment is thought to be an adaptive response of tumor cells to hypoxic environments. In recent years, it has been...
2.
Narisawa T, Naito S, Ito H, Ichiyanagi O, Sakurai T, Kato T, et al.
BMC Cancer
. 2023 Feb;
23(1):170.
PMID: 36803783
Background: Several clear cell renal cell carcinoma (ccRCC) cases harbour fibroblast growth factor receptor 4 (FGFR4) gene copy number (CN) gains. In this study, we investigated the functional contribution of...
3.
Kanno H, Naito S, Obara Y, Ito H, Ichiyanagi O, Narisawa T, et al.
Int J Mol Sci
. 2022 Aug;
23(15).
PMID: 35955582
(1) Background: Extracellular signal-regulating kinase 5 (ERK5) has been implicated in many cellular functions, including survival, proliferation, and vascularization. Our objectives were to examine the expression and effect of ERK5...
4.
Naito S, Narisawa T, Kato T, Ichiyanagi O, Kurokawa M, Yagi M, et al.
Int J Urol
. 2021 Feb;
28(4):450-456.
PMID: 33525046
Objectives: The utility of brain metastasis screening in asymptomatic metastatic renal cell carcinoma is controversial. Our study evaluated the utility of routine head computed tomography during systemic therapy. Methods: We...
5.
Nishida H, Fukuhara H, Yamagishi A, Hosoya N, Ichiyanagi O, Sakurai T, et al.
IJU Case Rep
. 2020 Aug;
3(3):86-89.
PMID: 32743478
Introduction: Heparin-induced thrombocytopenia is an antibody-mediated acquired prothrombotic state induced by heparin exposure. The risk of thromboembolic diseases in kidney transplantation with heparin-induced thrombocytopenia without perioperative anticoagulation has not been...
6.
Ichiyanagi O, Nishimoto K, Nagaoka A, Naito S, Yagi M, Ushijima M, et al.
Urol J
. 2020 Jul;
17(6):631-637.
PMID: 32715452
Purpose: We examined the associations between urethral sensation and storage/voiding function in female patients with detrusor overactivity (DO) by measuring urethral current perception threshold (CPT). Materials And Methods: We retrospectively...
7.
Ito S, Yamagishi A, Kurokawa M, Horie S, Yagi M, Kurota Y, et al.
Nihon Hinyokika Gakkai Zasshi
. 2020 Jul;
110(3):196-200.
PMID: 32684581
A 28-year-old male visited a nearby hospital with chief complaint of bilateral back pain and fever. He was diagnosed with a right complex renal cyst (Bosniak classification, IIF) with a...
8.
Naito S, Kato T, Ichiyanagi O, Narisawa T, Kurokawa M, Yagi M, et al.
Int J Urol
. 2020 Mar;
27(5):448-456.
PMID: 32207204
Objectives: To create a new model for the prediction of overall survival in synchronous metastatic renal cell carcinoma. Methods: Medical records of 158 patients with metastatic renal cell carcinoma diagnosed...
9.
Yamagishi A, Ichiyanagi O, Naito S, Ito H, Kabasawa T, Yamakawa M, et al.
Oncol Lett
. 2020 Jan;
19(1):885-891.
PMID: 31897203
Mesenchymal chondrosarcoma (MC) of the kidney is rare. To the best of our knowledge, the current report is the first case of a giant extraskeletal MC that arose primarily from...
10.
Naito S, Ichiyanagi O, Kato T, Kanno H, Narisawa T, Kurokawa M, et al.
Sci Rep
. 2019 Oct;
9(1):15451.
PMID: 31664053
Data on the outcomes of third- or fourth-line therapy for metastatic renal cell carcinoma (mRCC) are limited. The aim of our study was to evaluate the efficacy of therapy beyond...